Cellid, Co., Ltd. (KOSDAQ:299660)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2015
E-commerce	3.81B
New Drug Development	358.05M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2015
South Korea	4.17B
South Korea Growth	767.73%

Data Source: Finnhub Last updated: Dec 31, 2024

Financial data is provided by Finnhub and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 27, 2026

Data Sources Report a data error